The REGULATION (EU) 2024/1860 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices is published
OJ_L_202401860_AmendingRegulEUDAMED
Just in case you wish another language, here is the link : https://eur-lex.europa.eu/legal-content/FR/TXT/?uri=OJ:L_202401860